Whistleblower To Receive $10 Million In Drug Marketing Settlement
Such off-label drug marketing can result in improper billings to Medicare and/or Medicaid in violation of the federal False Claims Act. The False Claims Act allows whistleblowers to recover a percentage of the money recovered from companies sued for violating the law.
Source: New York Times
If you are aware of Medicare or Medicaid fraud, contact Lexington, Kentucky whistleblower lawyer Robert Abell at 859-254-7076.